Israel Cancer Association

The Israel Cancer Association is a registered charity, not a government body, and its own annual report states that its activity is made possible by public donations alone. Its distinctive contribution is that it started the screening: the national breast programme began nationally in 1995 after an Association awareness campaign from 1990, and the national colorectal programme, annual faecal occult blood testing from 50 to 74, began in 2005, both on its initiative with the Ministry of Health and the four health funds. It funds and assists the monitoring of the breast programme end to end, bought the first mobile mammography unit in 2001 and added a second with ultrasound in 2024, and reports about 22,600 mobile examinations in 2025.

Its appropriations in the 2025 financial year were 47.6 million shekels: 41.9 percent to rehabilitation and support including the Sir Charles Clore hostel, 29.6 percent to public information, education and early detection, 10.4 percent, about 5.0 million shekels, to research and clinical protocols, and the rest to administration, services and professional training. It reports more than 55 million shekels awarded to Israeli researchers over the past decade and lists 26 grants awarded in 2026 across eleven institutions. Services include support centres used by more than 12,000 patients and survivors, a breast-cancer survivor mentoring line, a hostel for patients in treatment, tutoring for children of patients, and a helpline for exercising rights against the health basket. The National Cancer Registry's own melanoma report credits part of the rise in in-situ melanoma detection to the Association's early-detection work with the health funds from the early 1990s. It does not run the cancer registry, which is a Ministry of Health function.